{
    "paper_id": "1de83283a1eb440e01e9157fdca275db28797020",
    "metadata": {
        "title": "Journal Pre-proof We are now planning for our recovery phase, while continuing to provide the safest care possible for our patients",
        "authors": [
            {
                "first": "E",
                "middle": [],
                "last": "Higgins",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "Walters",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "E",
                "middle": [],
                "last": "Powell",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "Staffurth",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Authors are required to identify the contributions for which they are responsible. The author responsible for the integrity of the entire study should be identified. Please list the following phrases and beside each indicate the name(s) of the author(s) to whom they apply: Items that do not apply should also be indicated with N/A. Where there is any uncertainty regarding authorship the editor of the study reserves the right to contact the guarantor of the study for further information.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Author Contributions"
        },
        {
            "text": "Authors: On 23 March 2020, the Government announced a period of lockdown. We compared the subsequent 3 weeks with the same period in 2019.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "Overall attendances to the radiotherapy department dropped by 28%. In the 2020 period, 74% of all attendances involved five tumour sites: breast (23%), urological (20%), head and neck (14%), colorectal (9%) and lung (8%). These figures were similar for 2019 except for urological sites due to (i) deferral of prostate radiotherapy and (ii) interim hormone treatment.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "The biggest changes have occurred in the use of fractionation regimens. For breast cancer, there was an increase in the use of five-fraction regimens, with 48% of patients receiving 26 Gy in five fractions in 2020, up from 13% in 2019. This was supported by international consensus guidelines, together with the Fast-forward trial [2, 3] .",
            "cite_spans": [
                {
                    "start": 331,
                    "end": 334,
                    "text": "[2,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 335,
                    "end": 337,
                    "text": "3]",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "For head and neck patients, there was an increase in the 20-fraction regimen. These accounted for 18% patients in 2020, compared with 10% in 2019. Thirty-fraction regimens increased to 82% from 70%; 0% attended for a 35-fraction regimen (compared with 10% in 2019). The consensus advice is to consider hypofractionated regimens [4].",
            "cite_spans": [],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "Short-course radiotherapy for rectal cancer has accounted for 75% of attendances in 2020 compared with 0% for 2019. International consensus guidelines advocate using shortcourse radiotherapy (25 Gy in five fractions) for patients traditionally treated with [AQ1]LCCRT [5] .",
            "cite_spans": [
                {
                    "start": 268,
                    "end": 271,
                    "text": "[5]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "The coronavirus epidemic has undoubtedly led to significant changes in the treatment of patients resulting from (i) changing referral patterns, (ii) treatment criteria and (iii) moving towards shorter fractionation schedules.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        },
        {
            "text": "We are now planning for our recovery phase, while continuing to provide the safest care possible for our patients. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "The impact of the Acute Phase of Covid-19 on radiotherapy demand in South East Wales"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Coles",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Aristei",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bliss",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Boersma",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Brunt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chatterjee",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Oncol",
            "volume": "32",
            "issn": "",
            "pages": "279--81",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial",
            "authors": [
                {
                    "first": "Murray",
                    "middle": [],
                    "last": "Brunt",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Haviland",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Wheatley",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Sydenham",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Alhasso",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bloomfield",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "28",
            "issn": "",
            "pages": "30932--30938",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic",
            "authors": [
                {
                    "first": "Cam",
                    "middle": [],
                    "last": "Marijnen",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "P"
                    ],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "R\u00f6del",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bujko",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Haustermans",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fokas",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Radiother Oncol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.radonc.2020"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "AQ1 SCRT has been changed to 'short-course radiotherapy'. Please spell out LCCRT (longcourse chemoradiotherapy?)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "E. Higgins, S. Walters, E. Powell, J. Staffurth Velindre Cancer Centre, Cardiff, UK",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Guarantor of integrity of the entire study-John Staffurth 2. Study concepts and design-Emma Higgins; Sarah Walters; John Staffurth 3. Literature research-Emma Higgins; Sarah Walters 4. Clinical studies-N/A 5. Experimental studies / data analysis-Emma Higgins; Sarah Walters; Emma Powell; John Staffurth 6. Statistical analysis-N/A 7. Manuscript preparation-Emma Higgins; Sarah Walters 8. Manuscript editing-Emma Higgins; Sarah Walters; John Staffurth",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Emma Higgins, Velindre Cancer Centre 2. Sarah Walters, Velindre Cancer Centre 3. Emma Powell, Velindre Cancer Centre 4. John Staffurth, Velindre Cancer Centre The Impact of the Acute Phase of COVID-19 on Radiotherapy Demand in South East Wales Madam -The coronavirus epidemic presents significant challenges to providing cancer care. Radiotherapy services need to depart from established pathways and protocols [1]. Here we summarise how COVID-19 has impacted local radiotherapy services.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "\u2612 The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.\u2610The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Declaration of interests"
        }
    ]
}